$0.00
0.00%
Nasdaq, Tue, Aug 20 2024
ISIN
US68234L2079
Symbol
ONCS

Key metrics

Market capitalization $0.00
EBIT (operating result TTM) EBIT $-32.65m
Short interest 3.70%

Is OncoSec Medical Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

OncoSec Medical Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast OncoSec Medical Incorporated:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast OncoSec Medical Incorporated:

Buy
100%

Financial data from OncoSec Medical Incorporated

Income Statement P&L | Balance Sheet | Cash Flow


Annually
Jul '22
+/-
%
- -
-
100%
- Direct Costs 1.07 1.07
1% 1%
-
-1.07 -1.07
1% 1%
-
- Selling and Administrative Expenses 9.06 9.06
25% 25%
-
- Research and Development Expense 26 26
24% 24%
-
-36 -36
24% 24%
-
- Depreciation and Amortization 1.07 1.07
1% 1%
-
EBIT (Operating Income) EBIT -37 -37
24% 24%
-
Net Profit -34 -34
24% 24%
-

In millions USD.

Don't miss a Thing! We will send you all news about OncoSec Medical Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OncoSec Medical Incorporated Stock News

Neutral
PRNewsWire
more than one year ago
EWING, N.J. and SAN DIEGO , May 18, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shar...
Positive
PennyStocks
more than one year ago
Hot penny stocks with big news this week. The post 3 Top Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Neutral
PRNewsWire
more than one year ago
EWING, N.J. and SAN DIEGO , May 16, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate disease, today announced that it has entered into a definitive agreement for the purchase and sale of  an agg...
More OncoSec Medical Incorporated News

Company Profile

OncoSec Medical, Inc. is a biotechnology company, which engages in designing, developing, and commercializing therapies for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.

Head office United States
CEO Robert Arch
Employees 41
Founded 2008
Website www.oncosec.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today